Jubilant Biosys, an Integrated CRDMO serving the global pharma industry for over two decades
Jubilant Biosys is recognized for its scientific Innovation and collaborative drug discovery programs with leading pharma and biotech companies. In a proactive initiative to keep pace with the ever evolving R&D industry landscape, Biosys has consolidated advances in Chemistry by utilizing the latest AI/ML technologies and by incorporation of environment friendly processes.

Jubilant Biosys - CDMO Infrastructure and Capabilities

ADCs Services

Explore advanced ADCs Services with Jubilant Biosys. We provide end-to-end antibody-drug conjugate solutions, including ADC design, linker and payload selection, conjugation, characterization, and analytical support. Backed by strong scientific expertise and cutting-edge technologies, our team helps accelerate ADC development with high-quality, reproducible results. Partner with Jubilant Biosys to advance innovative targeted therapies efficiently and confidently.

https://www.jubilantbiosys.com..../services/antibody-d

Advancing Drug Discovery Through Comprehensive DMPK Services at Jubilant Biosys

Effective Drug Metabolism and Pharmacokinetics (DMPK) studies form the cornerstone of modern drug discovery. At Jubilant Biosys, DMPK services are not just about data—they are about insights that shape smarter, faster, and safer drug development.

https://graph.org/Advancing-Dr....ug-Discovery-Through

Empowering Precision Medicine: Advanced ADC Services by Jubilant Biosys

As the pharmaceutical landscape continues to evolve, Antibody-Drug Conjugates stand at the forefront of modern therapeutics — delivering precise, potent, and safe treatments for complex diseases. Jubilant Biosys combines scientific excellence, cutting-edge technology, and deep therapeutic understanding to provide best-in-class ADC services across Oncology, CNS Disorders, Pain and Inflammation, and Metabolic Disorders.

https://medium.com/@jubilantbi....osys01/empowering-pr